Cerebellar damage can cause not only disturbance in motor control but also higher brain dysfunction known as cerebellar cognitive affective syndrome (CCAS). Although CCAS has a high prevalence, the precise mechanism and effective medications are unknown. We herein report a CCAS patient whose symptoms were ameliorated with the cholinesterase inhibitor donepezil. N-isopropyl-p-123 I-iodoamphetamine-singlephoton emission computed tomography showed improvement in hypoperfusion in the contralateral frontal and parieto-temporal lobes. Some projections with cholinergic transmission might form a functional connectivity between the cerebellum and contralateral association cortices, and cholinergic dysfunction is involved in CCAS pathophysiology. Donepezil might be worth considering for some CCAS patients.
Introduction
The cerebellum plays an important role in motor control. Cerebellar damage can cause disturbance in coordination, precision, and accurate timing of movements. In addition, anatomical, physiological, and functional neuroimaging studies have suggested that the cerebellum participates in the organization of higher-order functions. Some patients with cerebellar lesions experience memory impairment, attentional disturbance, executive dysfunction, and affective changes. These disorders of higher-order functions are recognized as cerebellar cognitive affective syndrome (CCAS) (1) . The pathophysiology of CCAS and effective medications have been unclear. We experienced a patient with CCAS whose higher brain dysfunction was ameliorated using the cholinesterase inhibitor donepezil and whose brain functional imaging showed improvement in the contralateral association area.
Case Report
A 60-year-old cognitively-normal right-handed man with a 10-year history of hypertension suddenly experienced vertigo and vomiting. He was diagnosed with right cerebellar hemorrhaging with a rupture into the cerebroventricle (Supplementary material 1). He underwent craniotomy to remove the hematoma. His physical condition fully recovered, and his neurological deficits were minimal, with slight dysarthria and wide-based walking five months later. However, mild memory disturbance and severe higher brain dysfunction including deficits in mental, attentional, and executive functions remained even at 10 months after the craniotomy.
Although he was not evaluated by neuropsychological tests during the acute or subacute phase, these impairments, as his wife described, appeared acutely after the stroke, were relatively stable, and followed a non-progressive course for 12 months. Ten months after the surgery, his score on the Revised Hasegawa's Dementia Scale (HDS-R), consisting of 9 simple questions with a maximum score of 30, was 27 points, and his full-scale intelligence quotient by the Japa- RT. MED LT. MED nese adult reading test was 100. However, he severely lacked initiative. He could accurately respond to some questions but needed some time to do so, and he never spoke first. His performance was also reduced on the backward condition of the digit span task; he was able to perform the task when three-digit numbers were given but could not when four-digit numbers were provided. His ability in the letter fluency task was also disturbed, as the number of words he was able to recall in 60 seconds was 4.3 on average. The percentage of correct answers and completion time were 60.5% and 160 seconds in the Visual Cancellation Task of a Letter, respectively. During the 4-disk Tower of Hanoi task, with a minimum number of steps of 15, he completed the task in 359 seconds after 55 steps. His standard profile score on the Rivermead Behavioral Memory Test (RBMT) was 14 points. Although brain MRI showed no abnormality in the left frontal or parieto-temporal lobe (Supplementary material 2), N-isopropyl-p-123 I-iodoamphetamine-( 123 I-IMP-) single-photon emission computed tomography (SPECT) showed hypoperfusion not only in the right cerebellum but also in the left frontal and parieto-temporal lobes. A three-dimensional stereotactic surface projection (3 D-SSP) analysis revealed a reduced regional cerebral blood flow (rCBF) clearly in the left superior frontal, left middle frontal, and left middle temporal gyri (Fig. 1A) compared to that on the opposite side in the lateral views (Fig. 1B) .
Based on these findings, he was diagnosed with CCAS, and the significant hypoperfusion in the left frontal and parieto-temporal lobes was recognized as crossed hemispheric diaschisis (2) . In addition, the decreased rCBF in the bilateral posterior cingulate gyri in the medial views ( Fig. 1C and D) , along with his mild memory disturbance, suggested the presence of Alzheimer disease (AD) pathology. He started taking donepezil. Over the next four months, his higher brain dysfunction gradually ameliorated, and he clearly became self-motivated. He was able to talk about what he thought and wanted to do. He re-started golf training for recreation. His HDS-R improved to the full score of 30 points. He was able to perform the backward digit span task even with five-digit numbers. His word recall improved to 6.0 on average in the letter fluency task. His percentage of correct answers increased to 82.5% in the Visual Cancellation Task of a Letter, although the completion time was slightly prolonged to 189 seconds. His standard profile score on the RBMT slightly improved to 15 points.
We expected that donepezil would partially improve his AD symptoms accompanied by improvement of the reduced rCBF in the bilateral posterior cingulate gyri. However, follow-up using 123 I-IMP-SPECT instead showed marked improvement in the hypoperfusion area and severity in the left frontal and parieto-temporal lobes ( Fig. 2A) , findings that did not markedly differ from those at the opposite side (Fig. 2B) . Also surprising was the fact that the reduced rCBF in the bilateral posterior cingulate gyri was not improved (Fig. 2C and D) ; quite the contrary, the area and Zscores increased. We therefore attributed the amelioration of his higher brain dysfunction, specifically his executive function and working memory domains, rather than his recent and delayed recall function, to the improvement of neuronal dysfunction associated with CCAS and not AD pathology. Ten months after taking donepezil, improvements in his executive function and working memory were also observed in the 4-disk Tower of Hanoi task; this time, he completed the task in 20 steps after 137 seconds.
Discussion
Cerebellar regions have functional connectivity with various cerebral areas, including the contralateral association cortices (3) (4) (5) . The constellation of deficits in CCAS suggests the disruption of neural circuits that link the prefrontal, posterior parietal, superior temporal, and limbic cortices with the cerebellum (1). In our patient, the areas where donepezil restored rCBF were mainly the left frontal and parieto-temporal association cortices. Although cholinergic deficits are well known to be present in AD and not CCAS, our patient showed marked improvements in his clinical symptoms and radiological findings with donepezil, suggesting that the cholinergic function is dysregulated in CCAS.
Although the prevalence of cognitive impairment caused by cerebellar hemorrhaging is very high (83.3%) after an evaluation, even with a simple screening test like the MiniMental State Examination (6), no effective treatment has yet been identified. In the present patient, however, there seemed to be some improvements during the psychological tests. Improvements were also observed by the patient himself, his wife, and his doctors. Furthermore, 123 I-IMP-SPECT showed that donepezil successfully ameliorated the reduced rCBF caused by CCAS and not AD pathology. We cannot completely deny the possibility that the improvement was due to the natural course of events after the surgery for cerebellar hemorrhaging and hydrocephalus. However, the probability of this being the case is low, as his improvement seemed to begin 12 months after his craniotomy, when donepezil was started. It is therefore possible that donepezil could thus be an effective treatment for his higher brain dysfunction.
In conclusion, some projections with cholinergic transmission may exist between the cerebellum and contralateral association cortices. Although further studies are required to confirm our findings, donepezil appears to be worth considering for the treatment of some CCAS patients.
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